US Patent Issued to Shandong Boan Biotechnology on Dec. 9 for "Anti-GPC3 antibody, anti-GPC3 chimeric antigen receptor and GPC3/CD3 bispecific antibody" (American, Chinese Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,252, issued on Dec. 9, was assigned to Shandong Boan Biotechnology Co. Ltd. (Shandong, China).

"Anti-GPC3 antibody, anti-GPC3 chimeric antigen receptor and GPC3/CD3 bispecific antibody" was invented by Avanish Varshney (Westford, Mass.), Kehao Zhao (Newton, Mass.), Li Zhou (West Roxbury, Mass.), Xin Kai (Woburn, Mass.), Liangjun Wei (Nanjing, China) and Ninghai Wang (Woburn, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are novel Glypican 3 (GPC3) antibodies or antigen binding fragments and GPC3/CD3 bispecific antibodies. The present application also provides chimeric antigen receptors comprising the antibodies or antigen-bindi...